Grass Pollen Allergy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

Published	Pages	Publisher	Report code
Apr 2022	48	Global Markets Direct	ASDR-600451

Published: Apr 2022 - Pages : 48 - Publisher : Global Markets Direct - Report code : ASDR-600451

Allergy Therapeutics Plc
ASIT Biotech SA
DC4U BV
H. Lundbeck AS
HAL Allergy BV
Regeneron Pharmaceuticals Inc
Revolo Biotherapeutics Ltd
Roxall Medizin GmbH
Worg Pharmaceuticals Hangzhou Co Ltd

Grass Pollen Allergy - Pipeline Review, H2 2020

This report can be of interest as well:

Grass Pollen Allergy - Pipeline Review, H2 2020

Published: August, 2020 | Report code: ASDR-563662